UBS Group’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.23M Buy
289,114
+77,108
+36% +$1.23M ﹤0.01% 4241
2025
Q4
$1.63M Buy
212,006
+49,932
+31% +$394K ﹤0.01% 5147
2025
Q3
$1.19M Buy
162,074
+72,360
+81% +$370K ﹤0.01% 5414
2025
Q2
$359K Buy
89,714
+53,320
+147% +$194K ﹤0.01% 6284
2025
Q1
$116K Sell
36,394
-15,715
-30% -$74K ﹤0.01% 6939
2024
Q4
$279K Buy
52,109
+36,428
+232% +$272K ﹤0.01% 6242
2024
Q3
$82.8K Buy
15,681
+2,681
+21% +$9.63K ﹤0.01% 6482
2024
Q2
$23.7K Buy
13,000
+8,321
+178% +$15.5K ﹤0.01% 7197
2024
Q1
$8.33K Sell
4,679
-2,021
-30% -$4.22K ﹤0.01% 7336
2023
Q4
$11.8K Hold
6,700
﹤0.01% 7379
2023
Q3
$9.78K Hold
6,700
﹤0.01% 7121
2023
Q2
$15.3K Sell
6,700
-4,314
-39% -$8.96K ﹤0.01% 6990
2023
Q1
$10K Buy
11,014
+6,314
+134% +$4.93K ﹤0.01% 7614
2022
Q4
$4K Sell
4,700
-17,956
-79% -$15.9K ﹤0.01% 9406
2022
Q3
$18K Buy
22,656
+85
+0.4% +$81 ﹤0.01% 7511
2022
Q2
$22K Buy
22,571
+8,464
+60% +$10.4K ﹤0.01% 6748
2022
Q1
$23K Buy
14,107
+4,837
+52% +$8.86K ﹤0.01% 7285
2021
Q4
$22K Buy
9,270
+6,270
+209% +$24.3K ﹤0.01% 7719
2021
Q3
$15K Hold
3,000
﹤0.01% 7493
2021
Q2
$8K Hold
3,000
﹤0.01% 8230
2021
Q1
$9K Sell
3,000
-7,043
-70% -$25.4K ﹤0.01% 7996
2020
Q4
$36K Buy
10,043
+5,740
+133% +$23.1K ﹤0.01% 6473
2020
Q3
$17K Buy
4,303
+3,584
+498% +$14.3K ﹤0.01% 6439
2020
Q2
$2K Sell
719
-2,097
-74% -$6.2K ﹤0.01% 7619
2020
Q1
$6K Buy
+2,816
New +$11.4K ﹤0.01% 7211
2019
Q3
Sell
-17
Closed 8026
2019
Q2
$0 Sell
17
-5,508
-100% -$21.6K ﹤0.01% 7898
2019
Q1
$22K Sell
5,525
-867
-14% -$3.66K ﹤0.01% 6219
2018
Q4
$23K Buy
+6,392
New +$43.6K ﹤0.01% 6665
2018
Q2
Sell
-1,776
Closed -$20K 8016
2018
Q1
$20K Sell
1,776
-7,531
-81% -$71.2K ﹤0.01% 6407
2017
Q4
$96K Buy
9,307
+7,977
+600% +$102K ﹤0.01% 5379
2017
Q3
$21K Buy
+1,330
New +$18.4K ﹤0.01% 6404
2017
Q2
Sell
-698
Closed -$15K 7713
2017
Q1
$15K Sell
698
-662
-49% -$10.4K ﹤0.01% 6350
2016
Q4
$19K Buy
+1,360
New +$20.7K ﹤0.01% 6540
2016
Q3
Sell
-1,419
Closed -$20K 7702
2016
Q2
$20K Buy
+1,419
New +$19.2K ﹤0.01% 6305

Other funds holding CRVS